Massivemarkets

SEC Form 4

Attovia Therapeutics, Inc. (ATTO) insider trading

In the 12 months to Nov 19, 2026, 2 ATTO insiders reported open-market sales of $4.5M across 2 filings; 6 insiders bought $52.4M.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$4.5M
2 filings · 2 insiders
Open-market purchases
$52.4M
6 filings

Who traded ATTO, and when

  • Purchase
  • Sale

ATTO daily close from Aug 5, 2026 to Nov 18, 2026, between $13.73 and $25.55, last $15.53. 2 sale and 6 purchase filings by 6 insiders, marked at their filing dates. Broad Street Principal Investments, L.L.C., Other: sold $2.3M and bought $10.3M across 2 filings, first filed Aug 28, 2026, last Aug 28, 2026. Colin Walsh, Director: sold $2.3M and bought $10.3M across 2 filings, first filed Aug 28, 2026, last Aug 28, 2026. Jeremy Green, 10% owner: bought $10.2M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026. FHMLS XI, L.L.C., 10% owner: bought $10.0M across 1 filing, first filed Aug 6, 2026, last Aug 6, 2026. venBio Global Strategic Fund IV, L.P., 10% owner: bought $6.5M across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026. Sanofi, 10% owner: bought $5.1M across 1 filing, first filed Aug 7, 2026, last Aug 7, 2026.

Largest mark · tap a row for others

Broad Street Principal Investments, L.L.C. · Other

Purchase $10,285,000

585,000 shares at $17.58 avg

Filed Aug 28, 2026 · traded Aug 5

Close on filing date $20.70

ATTO daily closelast $15.53

Broad Street Principal Investments, L.L.C. · Other

$2.3M sold$10.3M bought

Colin Walsh · Director

$2.3M sold$10.3M bought

Jeremy Green · 10% owner

$10.2M bought

FHMLS XI, L.L.C. · 10% owner

$10.0M bought

venBio Global Strategic Fund IV, L.P. · 10% owner

$6.5M bought

Sanofi · 10% owner

$5.1M bought
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

8 filings in the last 12 months
Other insider activity (not market trades) · 14 records
  • Other14 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Counted once
When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

Frequently asked questions

Has Attovia Therapeutics, Inc.'s CEO sold stock?

No. Tao Fu and Attovia Therapeutics, Inc. (CEOs) made no open-market sales filed as CEO in the last 12 months.

How current is ATTO’s insider data?

These are ATTO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track ATTO insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ATTO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.